Freighduff, Ireland

Marie Philippa Ryan

This inventor holds 1 USPTO granted patent. Top assignee: Teagasc. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marie Philippa Ryan: Innovator in Anti-Microbial Agents

Introduction

Marie Philippa Ryan is a notable inventor based in Freighduff, Ireland. She has made significant contributions to the field of microbiology, particularly in the development of novel anti-microbial agents. Her work focuses on bacteriocins, which are crucial in combating various bacterial strains.

Latest Patents

Marie Philippa Ryan holds a patent for a novel bacteriocin designated as lacticin 3147. This invention relates to an anti-microbial agent with nisin-like properties. The bacteriocin has a molecular weight of approximately 2.8 kDa and exhibits inhibiting activity against a range of bacteria, including lactococci, lactobacilli, enterococci, bacilli, leuconostocs, pediococci, clostridia, staphylococci, and streptococci. It is sensitive to proteases such as trypsin, alpha-chymotrypsin, proteinase K, and pronase E, but not to pepsin. Additionally, it demonstrates heat stability, activity at acid pH, and the capability of inhibiting nisin-producing bacterial strains.

Career Highlights

Marie is associated with Teagasc, where she continues her research and development in the field of microbiology. Her innovative work has positioned her as a key figure in the study of anti-microbial agents.

Collaborations

Some of her notable coworkers include Reynolds Paul Ross and Mary Clare Rea. Their collaborative efforts contribute to advancing research in the field of bacteriocins and anti-microbial agents.

Conclusion

Marie Philippa Ryan's contributions to the field of microbiology through her patent on lacticin 3147 highlight her role as an innovator in developing effective anti-microbial agents. Her work continues to impact the scientific community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…